首页> 外文期刊>Neurourology and urodynamics. >Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial
【24h】

Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial

机译:膀胱内注射肉毒杆菌毒素A可减轻常规治疗难以治疗的间质性膀胱炎/膀胱疼痛综合征的膀胱疼痛-前瞻性,多中心,随机,双盲,安慰剂对照临床试验

获取原文
获取原文并翻译 | 示例
       

摘要

PurposeIntravesical onabotulinumtoxinA (BoNT-A) injection is a beneficial treatment for interstitial cystitis/bladder pain syndrome (IC/BPS), yet its therapeutic efficacy remains to be validated. This study tests efficacy and safety of intravesical BoNT-A injections for treatment of IC/BPS.
机译:目的膀胱肉毒杆菌毒素A(BoNT-A)注射是治疗间质性膀胱炎/膀胱疼痛综合征(IC / BPS)的有益方法,但其疗效尚待验证。这项研究测试了膀胱内BoNT-A注射液治疗IC / BPS的有效性和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号